Spur Ventures II, LP 3
3 · CONSTELLATION PHARMACEUTICALS INC · Filed Jul 18, 2018
Insider Transaction Report
Form 3
Spur Ventures II, LP
10% Owner
Holdings
Series F Preferred Stock
→ Common Stock (136,254 underlying)Series E Preferred Stock
→ Common Stock (103,811 underlying)Series E-1 Preferred Stock
→ Common Stock (109,788 underlying)
Footnotes (4)
- [F1]The Series E Preferred Stock is convertible into Common Stock on a 8.56256-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F2]The securities are directly held by Spur Ventures II, L.P., and indirectly held by Spur Capital Partners, LLC, the manager of Spur Ventures II, L.P. Spur Capital Management II, LLC is the general partner of Spur Ventures II, L.P. Spur Capital Partners, LLC may be deemed to have voting and investment power with respect to such shares.
- [F3]The Series E-1 Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F4]The Series F Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.